article thumbnail

Warning of counterfeit ivermectin tablets sold via social media

Sciensano

Investigations show that these counterfeit ivermectin tablets are systematically underdosed or seriously contaminated with bacteria. Although several health authorities warned the public against using this medicine outside clinical trials, the medicine was widely used on a major scale in late 2020 and in 2021.

article thumbnail

Cyfendus Anthrax Vaccine Wins FDA Approval

XTalks

While there is no evidence of person-to-person transmission, anthrax skin lesions may be contagious through direct contact or contaminated objects. The bacteria usually enter the body through wounds, but infection can also occur through contaminated meat or inhalation of spores. Additionally, at Day 64, 86.6

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Highlights: Dec. 30, 2020

The Pharma Data

Some people in clinical trials of the Oxford-AstraZeneca vaccine were given the two doses several months apart. Also, a mouthwash is being recalled because it may be tainted with bacteria that are particularly dangerous for people with COVID-19, the U.S. Food and Drug Administration said. Shane Erickson Inc.

article thumbnail

A Comprehensive Guide to Help You Understand Toenail Fungus

Olympian Clinical Research

Fungal nail infections may also spread through contact with contaminated surfaces, such as public showers, pool decks, or locker room floors. Wearing the same pair of socks day after day may lead to the build-up of sweat and bacteria. Participate in a Clinical Trial on Toenail Fungus at Olympian Clinical Research.

article thumbnail

Improving quality control for CAR T cell therapies

Drug Discovery World

The immune system typically identifies foreign entities such as bacteria and viruses and activates lymphocytes such as T cells to destroy them with overwhelming force. And now, with more than 600 CAR T trials recruiting or ongoing, these cells represent a majority of the cellular immunotherapies in development today.

article thumbnail

FDA approves breakthrough pneumonia therapy

Pharmaceutical Technology

The intravenous therapy has become the first pathogen-targeted therapy approved for the treatment of hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex (ABC).